50
4
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T7541 |
PTP inhibitor 1
PTP Inhibitor II,alpha-溴-4-甲氧基苯乙酮 |
Phosphatase | Metabolism |
PTP inhibitor 1 是蛋白酪氨酸磷酸酶 (PTP) 抑制剂,具有抗血管生成作用。 | |||
T22137 |
PTP Inhibitor IV
|
Others | Others |
PTP Inhibitor IV 是一种有效的蛋白酪氨酸磷酸酶 (PTP) 抑制剂,可选择性抑制 DUSP14 磷酸酶活性(IC50 : 5.21 μM)。PTP Inhibitor IV 对 SHP-2、PTP1B、PTP-ε、PTP Meg-2、PTP-σ、PTP-β 和 PTP-μ具有抑制作用,IC50 分别为 1.8 μM、2.5 μM、8.4 μM、13 μM、20 μM、6.4 μM,和 6.7 μM。PTP Inhibitor IV 通过抑制PTP 活性,影响细胞信号传导,并可能调节与PTP 介导的信号传导事件相关的特定途径。 | |||
T10927 |
Cyt-PTPε Inhibitor-1
Cyt-PTP|A Inhibitor-1 |
Phosphatase; Src | Angiogenesis; Metabolism; Tyrosine Kinase/Adaptors |
Cyt-PTPε Inhibitor-1 (A Inhibitor-1) 是胞质蛋白酪氨酸磷酸酶 ε 的抑制剂。 Cyt-PTPε Inhibitor-1 阻断 c-Src 的去磷酸化并表现出抗破骨活性。 | |||
T12577 |
PTP1B-IN-3
|
Phosphatase | Metabolism |
PTP1B-IN-3 是一种具有有选择性和高效性的 PTP1B 抑制剂,具有抗癌活性,抑制 PTP1B 和 TCPTP 。PTP1B-IN-3 可用于研究糖尿病。 | |||
T6667 |
SF1670
PTP CD45 Inhibitor,PTPase CD45 Inhibitor |
Phosphatase; PTEN; Autophagy | Autophagy; Metabolism; PI3K/Akt/mTOR signaling |
SF1670 (PTPase CD45 Inhibitor) 是一种特异性 PTEN 抑制剂,IC50 为 2 μM。 | |||
T4256 |
PTP1B-IN-2
|
Phosphatase | Metabolism |
PTP1B-IN-2 是一种蛋白酪氨酸磷酸酶抑制剂,IC50=50 nM。 | |||
T7084 |
2-Bromo-4'-hydroxyacetophenone
SHP-1 Inhibitor II,PTP Inhibitor I,α-Bromo-4-hydroxyacetophenone,4-Hydroxyphenacyl bromide,2-溴-4'-羟基苯乙酮 |
Phosphatase | Metabolism |
2-Bromo-4'-hydroxyacetophenone(PTP Inhibitor I) 是一种PTP1B 的有效抑制剂,其Ki=42 μM。 | |||
T15243 |
Ertiprotafib
PTP 112 |
Phosphatase; PPAR | DNA Damage/DNA Repair; Metabolism |
Ertiprotafib is a PTP1B, IkB kinase β (IKK-β), and a dual PPARα and PPARβ agonist inhibitor ( IC50s: 1.6 μM for PTP1B, 400 nM for IKK-β, an EC50 of ~1 μM for PPARα/PPARβ). | |||
T39856 |
Purine riboside triphosphate
PTP,Purine riboside triphosphate |
||
Purine riboside triphosphate, a derivative of purine riboside, exhibits structural similarity to adenosine. This naturally occurring base analog possesses inhibitory effects on carcinogenic growth, particularly in cancer ascites cells, by strongly impeding RNA and DNA synthesis. | |||
T80870 | VE-PTP-IN-1 | ||
VE-PTP-IN-1 (compound 2) 为一种选择性VE-PTP抑制剂,呈弱酸性,涉及调控血管稳态及血管生成。 | |||
T40745 |
PTP1B-IN-13
PTP1B-IN-13 |
||
PTP1B-IN-13, a potent and selective inhibitor of Protein Tyrosine Phosphatase 1B (PTP1B), effectively targets the allosteric site, exhibiting an IC50 value of 1.59 μM. | |||
T40835 |
PTP1B-IN-14
PTP1B-IN-14 |
||
PTP1B-IN-14 is a selective PTP1B inhibitor ( IC 50 = 0.72 μM) targeting the allosteric site. | |||
T12579 |
RAMB4
PTP1B-IN-9 |
Proteasome | Proteases/Proteasome; Ubiquitination |
RAMB4 (PTP1B-IN-9) 是一种泛素-蛋白酶体系统(UPS)应激源,是通过抑制 20S 蛋白酶体催化活性物质上游泛素介导的蛋白质降解而产生。它能够在不影响 20S 蛋白酶体催化活性的情况下触发泛素蛋白酶体系统 (UPS) 应激反应。 | |||
T67893 |
PTP1B-IN-22
|
Phosphatase | Metabolism |
PTP1B-IN-22是一种蛋白酪氨酸磷酸酶1B (PTP1B)抑制剂,可抑制骨骼肌 L6肌管的葡萄糖摄取。 | |||
T4340 |
SPI-112
|
Phosphatase | Metabolism |
SPI 112 是一种选择性的、有效的、竞争性的SHP2 (PTPN11)抑制剂,对SHP2,蛋白酪氨酸磷酸酶 (PTP) 和 PTP1B 的IC50分别为 1 μM,18.3 μM 和 14.5 μM。 | |||
T7356 |
PTP1B-IN-1
PTP1B inhibitor,5-苯基-1,2,5-噻二唑烷-3-酮 1,1-二氧化物 |
Phosphatase | Metabolism |
PTP1B-IN-1 (PTP1B inhibitor) 是一种蛋白质酪氨酸磷酸酶 1B 的有效抑制剂 (IC50 : 1.6 mM) | |||
T24073 |
PTP1B-IN-4
NUN 17724,PTP1B-inhibitor-2,PTP1B IN 2,PTP1B-IN-2,PTP1B-inhibitor-4,FRJ,PTP1B inhibitor 4,NUN17724,PTP1B inhibitor 2,PTP1BIN2,NUN-17724 |
Phosphatase | Metabolism |
PTP1B-IN-4 (NUN-17724)是一种 PTP1B 的变构抑制剂,IC50为8μM。PTP1B-IN-4可用于肥胖症和糖尿病的研究。 | |||
T61851 | PTP1B-IN-3 diammonium | ||
PTP1B-IN-3 diammonium is a highly effective and orally bioavailable inhibitor of the protein tyrosine phosphatase 1B (PTP1B) enzyme, with an IC50 value of 120 nM for both PTP1B and TCPTP. This compound exhibits potent antidiabetic and anticancer properties, as supported by extensive research [1] [2]. | |||
T63739 |
PTP1B-IN-15
|
||
PTP1B-IN-15 是有效的、选择性的蛋白酪氨酸磷酸酶 1B (PTP1B) 抑制剂,对II 型糖尿病和肥胖症表现出研究潜力。 | |||
T80544 |
PTPσ Inhibitor, ISP
|
Phosphatase | Metabolism |
PTPσ Inhibitor, ISP 结合并抑制重组人PTPσ的信号传导,具有穿透细胞膜的能力,有助于缓解CSPG介导的脊髓损伤模型中轴突的生长抑制。该抑制剂能增强LPC引起的脊髓脱髓鞘损伤的髓鞘再生,并在MS动物模型中促进OPC的迁移、分化、髓鞘形成及功能恢复。 | |||
T63022 | PTP1B-IN-18 | ||
PTP1B-IN-18 是一种口服具有活力的完全混合型蛋白酪氨酸磷酸酶 1B (PTP1B) 抑制剂 (Ki: 35.2 μM)。PTP1B-IN-18 能够用于研究 2 型糖尿病。 | |||
T22276 |
Bis(maltolato)oxovanadium(IV)
双(麦芽醇)氧钒(IV),BMOV,Bis maltolato oxovanadium,Bis(maltolato)oxovanadium (IV),bis maltolato oxo vanadium,Bis(maltolato)oxovanadium (IV) |
Phosphatase; Others | Metabolism; Others |
Bis(maltolato)oxovanadium(IV) (BMOV) 是一种有效的胰岛素增敏剂,也是一种有效的、竞争性的、可逆的、口服具有活性的光谱蛋白酪氨酸磷酸酶 (PTP) 抑制剂。它抑制HCPTPA,PTP1B,HPTPβ和SHP2的IC50分别为 126 nM,109 nM,26 nM 和 201 nM。 | |||
T63023 | PTP1B-IN-19 | ||
PTP1B-IN-19 (Compound 43) 是一种有潜力的选择性苯并咪唑衍生物,能够作为蛋白质酪氨酸磷酸酶 1B (PTP1B) 抑制剂 (Ki: 23.3 μM)。PTP1B-IN-17 能够用于研究 2 型糖尿病。 | |||
T63435 | PTP1B-IN-16 | ||
PTP1B-IN-16 是有潜力的、选择性的苯并咪唑衍生物,也是一种蛋白质酪氨酸磷酸酶 1B (PTP1B) 抑制剂 (Ki: 12.6 μM)。PTP1B-IN-16 能够用于研究 2 型糖尿病。 | |||
T63021 | PTP1B-IN-17 | ||
PTP1B-IN-17 (Compound 45) 是一种有潜力的选择性苯并咪唑衍生物,能够作为蛋白质酪氨酸磷酸酶 1B (PTP1B) 抑制剂 (Ki: 30.2 μM)。PTP1B-IN-17 能够用于研究 2 型糖尿病。 | |||
T78703 |
PTP1B/AKR1B1-IN-2
|
Phosphatase | Metabolism |
PTP1B/AKR1B1-IN-2(化合物7f)是一种双重PTP1B/AKR1B1抑制剂,具有IC50:3.2和2.1 μM,Ki:4.0和0.9μM。该化合物作为胰岛素模拟剂,能够改善小鼠C2C12肌母细胞的葡萄糖摄取,并可用于2型糖尿病(T2DM)的研究。 | |||
T78702 |
PTP1B/AKR1B1-IN-1
|
Phosphatase | Metabolism |
PTP1B/AKR1B1-IN-1是一种针对PTP1B和AKR1B1的双重抑制剂,其IC50值分别为0.06 μM和4.3 μM。该化合物也能抑制TC-PTP,IC50为9 μM。在小鼠成肌细胞中,PTP1B/AKR1B1-IN-1作为胰岛素模拟剂使用,并能减少AKR1B1依赖的山梨醇积累,有助于抑制2型糖尿病的发展并控制血糖水平。 | |||
T4491 |
LMPTP INHIBITOR 1 hydrochloride
LMPTP INHIBITOR 1 hydrochloride (1908414-82-3(free base)) |
Phosphatase | Metabolism |
LMPTP INHIBITOR 1 hydrochloride 是一种高选择性的低分子量蛋白酪氨酸磷酸酶 (LMPTP) 抑制剂。LMPTP INHIBITOR 1 (hydrochloride) 能够抑制 LMPTP-A 的活性,IC50值为 0.8 μM。 | |||
T41298 |
LMPTP INHIBITOR 1 dihydrochloride
|
Phosphatase | Metabolism |
LMPTP INHIBITOR 1 dihydrochloride 是选择性的低分子量蛋白酪氨酸磷酸酶(LMPTP)抑制剂,抑制 LMPTP-A 活性的IC50为 0.8 μM。 | |||
T4081 |
MPTP hydrochloride
MPTP-hydrochloride |
Apoptosis; Dopamine Receptor | Apoptosis; GPCR/G Protein; Neuroscience |
MPTP hydrochloride 是 MPP+ 的前体,是一种多巴胺神经毒素,具有血脑屏障渗透性。MPTP hydrochloride 对多巴胺能神经元有毒,可以导致帕金森症,被广泛应用于帕金森动物模型的构建。 | |||
T71739 |
PTPMT1-IN-1
|
||
PTPMT1-IN-1 is a PTEN-like mitochondrial phosphatase PTPMT1 inhibitor. | |||
T79160 |
PROTAC PTPN2 degrader-2
|
Phosphatase | Metabolism |
PROTACPTPN2 degrader-2(example 187B)作为PTPN2降解剂,展现出对研究癌症和代谢性疾病的有效性。 | |||
T73120 | MptpB-IN-1 | ||
MptpB-IN-1 是一种有效的、具有口服活性的 MptpB 抑制剂。结核分枝杆菌蛋白-酪氨酸-磷酸酶 B (MptpB) 是一种分泌的毒力因子,可破坏宿主的抗菌活性。MptpB-IN-1 可降低耐多药结核分枝杆菌的存活率和感染负担。 | |||
T74732 |
PROTAC PTPN2 degrader-1
|
||
PROTACPTPN2 degrader-1 (compound example 77) 是一种有效的 PTPN2降解剂。PROTACPTPN2 degrader-1 具有研究癌症或代谢性疾病的潜力。 | |||
T71195 |
mPTP-IN-22
|
||
mPTP-IN-22 is a novel mitochondrial permeability transition pore (mptp) inhibitor | |||
T40216 |
PTPN22-IN-1
PTPN22-IN-1 |
||
PTPN22-IN-1 is a potent PTPN22 inhibitor ( IC 50 =1.4 μM; K i =0.50 μM). PTPN22-IN-1 exhibits >7-10 fold selectivity for PTPN22 over similar phosphatases. PTPN22-IN-1 augments antitumor immune responses. From WO2021007491A1 compound L-1. | |||
T79161 |
PROTAC PTPN2 degrader-2 TFA
|
Phosphatase | Metabolism |
PROTACPTPN2 degrader-2(例187B)TFA 作为PTPN2降解剂,展现出对癌症及代谢性疾病研究的潜在效用。 | |||
T79479 |
MptpB-IN-2
|
Antibiotic | Microbiology/Virology |
MptpB-IN-2(化合物20)是一种高选择性的结核分枝杆菌蛋白酪氨酸磷酸酶B(MptpB)抑制剂,其对MptpB、MptpA和PTP1B的IC50值分别为0.64 μM、4.06 μM和4.14 μM。此化合物对Mtb H37Rv表现出较低的抗结核活性,MIC为64.9 μM。 | |||
T13176 |
TNO155
Batoprotafib |
Phosphatase | Metabolism |
TNO155 是具有口服活性野生型SHP2的选择性变构抑制剂 (IC50= 0.011 µM)。它有研究 RTK 依赖性恶性肿瘤(尤其是晚期实体瘤)的潜力。 | |||
T14841 |
BVT948
|
Phosphatase; P450; Histone Methyltransferase | Chromatin/Epigenetic; Metabolism |
BVT948 是一种蛋白酪氨酸磷酸酶抑制剂,还可以抑制赖氨酸甲基转移酶 SETD8 (KMT5A) 和几种细胞色素 P450 (P450) 同工型。 | |||
T16724 |
Razuprotafib
AKB-9778 |
Phosphatase; Others | Metabolism; Others |
Razuprotafib (AKB-9778) 是一种 VE-PTP (HPTPß)催化活性的有效选择性抑制剂,抑制结构相关磷酸酶 PTP1B。除 HPTPη 和 HPTPγ 外,它对 VE-PTP 具有良好的选择性。它能够促进 TIE2 活化,增强 ANG1 诱导的 TIE2 活化,并刺激 TIE2 通路中信号分子的磷酸化。 | |||
T10594 | bpV(phen) | PTEN | PI3K/Akt/mTOR signaling |
bpV(phen) is a potent protein tyrosine phosphatase (PTP) and PTEN inhibitor (IC50s: 343 nM, 920 nM, and 38 nM for PTP-β, PTP-1B, and PTEN). | |||
T73477 | SHP844 | ||
SHP844为一SHP2抑制剂,IC50值为18.9 µM。SHP2为蛋白酪氨酸磷酸酶(PTP),调控酪氨酸磷酸化水平,影响细胞增殖、分化及存活。 | |||
T82056 | IP2 | ||
IP2作为免疫调节剂,能增强癌细胞内PTP衍生的抗原呈递,但对癌细胞本身不具有细胞毒性。在小鼠实验中,IP2能诱导肿瘤生长缺陷。 | |||
T62442 |
MY33-3 hydrochloride
|
||
MY33-3 hydrochloride 是一种有效的、选择性的蛋白酪氨酸磷酸酶 RPTPβ/ζ 抑制剂 (IC50~0.1 μM)。MY33-3 hydrochloride 对 PTP-1B 具有抑制作用 (IC50~0.7 μM)。MY33-3 hydrochloride 能够降低乙醇消耗,缓解 Sevoflurane 引起的神经炎症和认知功能障碍。 | |||
T41370 |
(Rac)-RK-682
|
||
(Rac)-RK-682 是 RK-682 的外消旋体。(Rac)-RK-682 是一种蛋白质酪氨酸磷酸酶 (PTPases) 抑制剂。(Rac)-RK-682 抑制蛋白酪氨酸磷酸酶 1B (PTP-1B)、低分子量蛋白酪氨酸磷酸酶 (LMW-PTP)、细胞分裂周期 25B (CDC-25B),IC50分别为 8.6 μM、12.4 μM 和 0.7 μM。 | |||
T74980 | SPAA-52 | ||
SPAA-52 是一种具有口服活性的、竞争性的和可逆的低分子量蛋白酪氨酸磷酸酶 (LMW-PTP) 抑制剂 (IC50=4 nM,Ki=1.2 nM)。SPAA-52 可用于糖尿病的研究。 | |||
T79644 |
Antidiabetic agent 2
|
Glucosidase | Metabolism |
Antidiabetic agent 2 (Compound 56) 作为一种葡萄糖摄取促进剂,能有效地抑制DPP-4, PTP-1B, α-淀粉酶和α-葡萄糖苷酶,其IC50s分别达到0.036、0.042、0.241、0.185 μM,表现出显著的降血糖作用。 | |||
T28901 |
T-2007
5,5-Diphenylbarbituric acid,DPB |
||
T-2007 is an α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist and gamma-aminobutyric acid (GABA) receptor agonist. T2007 and its analogs upregulates CYP3A4 and MDR1. T-2007 depressed both the degree and the duration of postt | |||
T39677 |
MY33-3
MY33-3 |
||
MY33-3 is a powerful and specific inhibitor of receptor protein tyrosine phosphatase (RPTP)β/ζ, demonstrating an IC50 value of approximately 0.1 μM. Moreover, MY33-3 exhibits inhibitory activity against PTP-1B with an IC50 value of about 0.7 μM. Additionally, MY33-3 has been shown to effectively decrease ethanol consumption and alleviate neuroinflammation and cognitive dysfunction induced by Sevoflurane. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T73073 |
PTP1B-IN-21
|
||
PTP1B-IN-21 是蛋白酪氨酸磷酸酶 1B (PTP1B) 的选择性抑制剂 (IC50=1.56 μM),抑制力超出高度同源 T 细胞蛋白酪氨酸磷酸酶 (TCPTP;IC50>100 μM),PTP1B 是抑制 2 型糖尿病的重要靶点。 | |||
T73072 |
PTP1B-IN-20
|
||
PTP1B-IN-20 是蛋白酪氨酸磷酸酶 1B (PTP1B) 的选择性抑制剂 (IC50=1.05 μM),抑制力超出高度同源 T 细胞蛋白酪氨酸磷酸酶 (TCPTP;IC50=78.0 μM),PTP1B 是抑制 2 型糖尿病的重要靶点。 | |||
T39219 | Ficusonolide | ||
Ficusonolide exhibits significant antidiabetic activity through its interactions with dipeptidyl peptidase-IV (DPP-IV), protein tyrosine phosphatase 1B (PTP-1B), α-glucosidase, and α-amylase. | |||
T3930 |
Taraxerol acetate
醋酸蒲公英霜,Taraxeryl acetate |
Phosphatase; HSV | Metabolism; Microbiology/Virology |
Taraxeryl acetate shows the significant antiviral activity against herpes simplex virus (type II). It has less effect on cell cycle arrest and apoptosis of AGS cells than taraxerol. A. roxburghiana has antidiabetic activity, could be attributed due to PTP |